Caroline Baumal, Chief Medical Officer: Apellis Pharmaceuticals APLS Sell · Filed 25/01/21

Trade details

Type: Insider sale
Amount: $55,515.88
Shares · price: 1,853 sh · $29.96 a share
Held after: 53,707.37 sh
Stock: Apellis Pharmaceuticals APLS
Person: Caroline BaumalChief Medical Officer
Trade date: 25/01/17
Filed: 25/01/21
Days to filing: 4 days

Sold 3.3% of holdings

Share of holding sold: 3.3%

Apellis Pharmaceuticals trades, last 26 weeks

What else happened in Apellis Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/12/18~25/02/16

Caroline Baumal's recent trades

Caroline BaumalChief Medical Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$60.9K
2,797 sh
$60.9K
Filed 01/23
Traded 01/22
Caroline BaumalChief Medical Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$37.2K
1,882 sh
$37.2K
Filed 01/21
Traded 01/20
Caroline BaumalChief Medical Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$77.1K
3,020 sh
$77.1K
Filed 01/06
Traded 01/05
Caroline BaumalChief Medical Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$95.2K
2,816 sh
$95.2K
Filed 25/01/08
Traded 25/01/06
Caroline BaumalChief Medical Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$165.2K
2,751 sh
$165.2K
Filed 24/01/05
Traded 24/01/04